Antibodies and molecules derived therefrom that bind to steap-1 proteins
CA 2563735 C · Owner: Jia, Xiao-Chi · Inventors: Faris, Mary; Etessami, Soudabeh; Challita-Eid, Pia M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof are , described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently STEAP-1 provides a , diagnostic, prognostic prophylactic and/or therapeutic target for cancer. The STEAP-1 gene or fragment thereof or its encoded , protein, or variants thereof or a fragment thereof, can be used , to elicit a humoral or cellular immune response; antibodies or T cells reactive with STEAP-1 can be used in active or passive immunization.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 22, 2004 and granted July 14, 2020. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 22, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 22, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.